WDR19 Gene Cranioectodermal Dysplasia Type 4 Genetic Test sale cost 4400 AED
BDNF Gene Central Hypoventilation Syndrome Congenital Genetic Test sale cost 4400 AED BDNF Gene Central Hypoventilation Syndrome Congenital Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DISP1 Gene Craniofacial and Neuro-Developmental Abnormalities Genetic Test sale cost 4400 AED DISP1 Gene Craniofacial and Neuro-Developmental Abnormalities Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

WDR19 Gene Cranioectodermal Dysplasia Type 4 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The WDR19 gene plays a crucial role in human development, and mutations in this gene can lead to Cranioectodermal Dysplasia Type 4, a rare genetic disorder. This condition is characterized by abnormalities in the development of the skull, face, limbs, and other parts of the body. To diagnose this specific form of dysplasia, genetic testing is essential.

At DNA Labs UAE, a specialized genetic test is available to identify mutations in the WDR19 gene, thereby confirming a diagnosis of Cranioectodermal Dysplasia Type 4. This test is crucial for affected individuals and their families, as it provides essential information for understanding the condition, potential treatments, and the risk of passing the mutation to future generations.

The cost of the WDR19 Gene Cranioectodermal Dysplasia Type 4 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the subsequent laboratory analysis to detect any mutations in the WDR19 gene. Given the complexity of genetic testing and the specialized analysis required, the cost reflects the expertise and technology utilized to provide accurate and reliable results.

For families facing the possibility of Cranioectodermal Dysplasia Type 4, this test offers a vital step towards understanding and managing the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test

Introduction

The WDR19 gene is associated with cranioectodermal dysplasia type 4 (CED4), a rare genetic disorder characterized by abnormalities in the development of the craniofacial structures, ectodermal tissues, and skeletal system.

Test Details

The WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test is a NGS (Next-Generation Sequencing) genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. This test specifically identifies mutations or variants in the WDR19 gene that are associated with CED4.

Components

  • Test Name: WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test gene WDR19.

Procedure

The test involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the WDR19 gene.

Results and Interpretation

The results of the test can help confirm a diagnosis of CED4 and provide information about the specific genetic variant present. It is crucial to consult with a healthcare professional or genetic counselor to interpret the results and receive appropriate counseling and support for individuals and families affected by CED4.

Test Name WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test gene WDR19
Test Details

The WDR19 gene is associated with cranioectodermal dysplasia type 4 (CED4), a rare genetic disorder characterized by abnormalities in the development of the craniofacial structures, ectodermal tissues, and skeletal system.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of CED4, NGS genetic testing can be used to identify mutations or variants in the WDR19 gene that are associated with the disorder.

NGS genetic testing for CED4 involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the WDR19 gene. The results of the test can help confirm a diagnosis of CED4 and provide information about the specific genetic variant present.

It is important to note that genetic testing for CED4 and other genetic disorders should be done under the guidance of a healthcare professional or genetic counselor. They can help interpret the results of the test and provide appropriate counseling and support for individuals and families affected by CED4.

SKU: TEST-4070 Category:

Related products